THC
22%
CBD
1%
Trilogy is a hybrid from Exotic Genetix Seeds with THC testing up to 22 percent and roughly 1 percent CBD content.
No effect, terpene, flavor or medical-use data specific to Trilogy has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
22% THC
Growing Information
Flowering Time
8–9 weeks
About Trilogy
Trilogy, offered through Exotic Genetix Seeds, is a hybrid with THC testing up to 22 percent and a touch of CBD, around 1 percent, rounding out the cannabinoid profile. Flowering finishes in eight to nine weeks, a standard window for a modern hybrid. No specific lineage, flavor, or yield data has been logged for this particular cut, so the name itself, suggesting a three-part story or a three-strain heritage, remains unconfirmed by the actual record. What is documented points to a moderately fast, fairly potent hybrid with just enough CBD present to be worth noting alongside the THC figure. Growers curious about the name's backstory will need to wait for more details to surface.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Trilogy
Is Trilogy an Indica, Sativa, or Hybrid?
Trilogy is classified as a hybrid cannabis strain bred from a genetic cross of otic Geneti × Seed Bank Mother.
What cannabinoid content is reported for Trilogy?
Trilogy: 22% THC and 1% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.